CCCC vs RGNX: stock comparison and AI forecast
C4 Therapeutics, Inc. (CCCC) and Regenxbio Inc. (RGNX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CCCC C4 Therapeutics, Inc.
- Market Cap
- $395M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
RGNX Regenxbio Inc.
- Price
- $7.16 -23.7% · 6M
- Market Cap
- $473M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- RGNX is 1.2 times larger than CCCC by market capitalization ($473M against $395M).
- RGNX turns -116.9% of its revenue into net income, against -289.4% for CCCC.
- RGNX carries 4.39 times debt per unit of equity, against 0.45 times for CCCC.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CCCC | RGNX |
|---|---|---|
| Market Cap | $395M | $473M |
| P/B Ratio | 1.60x | 6.59x |
| EPS | $-1.08 | $-3.67 |
| Book Value/Share | $2.01 | $1.09 |
| Revenue/Share | $0.28 | $2.55 |
| FCF/Share | $-0.69 | $-3.78 |
Profitability & Margins
| Metric | CCCC | RGNX |
|---|---|---|
| ROE | -41.0% | -273.7% |
| ROA | -28.2% | -50.8% |
| ROIC | -35.9% | -54.0% |
| Operating Margin | -319.0% | -97.7% |
| Net Margin | -289.4% | -116.9% |
| EBT Margin | -304.6% | -117.1% |
| Tax Rate | -0.1% | – |
Financial Health
| Metric | CCCC | RGNX |
|---|---|---|
| Current Ratio | 5.45x | 2.86x |
| D/E Ratio | 0.45x | 4.39x |
| Financial Leverage | 1.45x | 5.39x |
| Interest Coverage | 43.9x | -124.8x |
| Working Capital | $215M | $154M |
Cash Flow
| Metric | CCCC | RGNX |
|---|---|---|
| Operating Cash Flow | -$85M | -$247M |
| Free Cash Flow | -$85M | -$250M |
| Capital Spending | -$520K | -$3M |
| FCF/Sales | -243.7% | -148.5% |
| CapEx/Sales | 1.5% | 1.8% |
Operational Efficiency
| Metric | CCCC | RGNX |
|---|---|---|
| Asset Turnover | 0.10x | 0.43x |
| Receivables Turnover | 26.3x | 1.6x |
| Fixed Assets Turnover | 8.4x | 1.7x |
| Days Sales Outstanding | 14 days | 232 days |
Income Statement
| Metric | CCCC | RGNX |
|---|---|---|
| Total Revenue | $35M | $168M |
| Operating Income | -$112M | -$164M |
| Net Income | -$101M | -$196M |
| R&D Expense | $100M | $229M |
Dividend & Shareholder Information
| Metric | CCCC | RGNX |
|---|---|---|
| Shares Outstanding | 123M | 66M |
CCCC vs RGNX: stock comparison and AI forecast
Which is bigger, CCCC or RGNX?
RGNX is 1.2 times larger than CCCC by market capitalization ($473M against $395M).
Which one does Intratio's AI model rank higher, CCCC or RGNX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.